Papilomatose de laringe
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Clinical and Biomedical Research |
Texto Completo: | https://seer.ufrgs.br/index.php/hcpa/article/view/125224 |
Resumo: | Laryngeal papillomatosis is the most frequent benign neoplasm of the larynx, occurring in children and adults. It is caused by the human papilloma virus, especially types 6 and 11. The clinical course is unpredictable and recurrence is frequent in children. There have been reports of association between this disease and tracheobronchial tree and squamous cell carcinoma of the larynx. Papillomatosis is probably one of thefactors that can predispose a patient to the development of cancer, similarly to alcohol, tobacco, and radiation exposure.Treatment aims at maintaining airway patency and speech. Surgery with carbon dioxide laser is able to achieve this objective, however, without preventing recidivation. The low rates of surgical cure have been stimulating new research with chemotherapics. Unfortunately these have not been successful. Their main purpose is to reduce the extension of the disease and rates of recidivation, slowing down papilloma growth.The present study reviews pathophysiology, the clinical presentation and treatment aspects . |
id |
UFRGS-20_0a985fbcf020d4044169fcc553261cc7 |
---|---|
oai_identifier_str |
oai:seer.ufrgs.br:article/125224 |
network_acronym_str |
UFRGS-20 |
network_name_str |
Clinical and Biomedical Research |
repository_id_str |
|
spelling |
Papilomatose de laringePapilomatose de laringePapilomatose laríngeapapiloma vírus humano (HPV)laser CO2tratamento adjuvanteLaryngeal papillomatosishuman papilloma virus (HPV)carbon dioxide laseradjuvant treatmentLaryngeal papillomatosis is the most frequent benign neoplasm of the larynx, occurring in children and adults. It is caused by the human papilloma virus, especially types 6 and 11. The clinical course is unpredictable and recurrence is frequent in children. There have been reports of association between this disease and tracheobronchial tree and squamous cell carcinoma of the larynx. Papillomatosis is probably one of thefactors that can predispose a patient to the development of cancer, similarly to alcohol, tobacco, and radiation exposure.Treatment aims at maintaining airway patency and speech. Surgery with carbon dioxide laser is able to achieve this objective, however, without preventing recidivation. The low rates of surgical cure have been stimulating new research with chemotherapics. Unfortunately these have not been successful. Their main purpose is to reduce the extension of the disease and rates of recidivation, slowing down papilloma growth.The present study reviews pathophysiology, the clinical presentation and treatment aspects .A papilomatose de laringe é a neoplasia benigna que mais freqüentemente acomete a laringe, tanto em crianças quanto em adultos. É causada pelo papiloma vírus humano, em especial pelos tipos 6 e 11. A apresentação clínica é variável e a evolução praticamente imprevisível, devido especialmente ao alto grau de recorrência típico desta entidade. Existem diversos relatos que demonstram associação entre estadoença e o carcinoma de células escamosas de laringe e de árvore traqueobrônquica. Acredita-se que a papilomatose seja um dos fatores que predisponham o paciente ao câncer, assim como o são o álcool, o fumo e a exposição à radiação ionizante. O objetivo do tratamento é a manutenção da via aérea e da função vocal. Para tanto, a microcirurgia com laser tem demonstrado os melhores resultados, apesar de nãoimpedir as recorrências. Assim, os pobres índices de cura cirúrgica têm estimulado o desenvolvimento de estudos com quimioterápicos. A proposta do uso destes é reduzir a extensão da doença e a freqüência das recidivas, lentificando o crescimento do papiloma. Essas terapias adjuvantes, entretanto, ainda apresentam pouco sucesso a longo prazo. Realizamos aqui uma revisão da literatura a respeito do assunto, com ênfase nos aspectos de fisiopatologia, apresentação clínica e tratamento.HCPA/FAMED/UFRGS2022-06-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPeer-reviewed Article"A Convite dos Editoresapplication/pdfhttps://seer.ufrgs.br/index.php/hcpa/article/view/125224Clinical & Biomedical Research; Vol. 19 No. 2 (1999): Revista HCPAClinical and Biomedical Research; v. 19 n. 2 (1999): Revista HCPA2357-9730reponame:Clinical and Biomedical Researchinstname:Universidade Federal do Rio Grande do Sul (UFRGS)instacron:UFRGSporhttps://seer.ufrgs.br/index.php/hcpa/article/view/125224/85175http://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessvon Mülen, Carla Rigol, Cristiane Melchior, Raquel Argenta, Rodrigo M. Smith, Mariana S. Miura, Maurício Kuhl, Gabriel 2022-06-13T13:38:54Zoai:seer.ufrgs.br:article/125224Revistahttps://www.seer.ufrgs.br/index.php/hcpaPUBhttps://seer.ufrgs.br/index.php/hcpa/oai||cbr@hcpa.edu.br2357-97302357-9730opendoar:2022-06-13T13:38:54Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS)false |
dc.title.none.fl_str_mv |
Papilomatose de laringe Papilomatose de laringe |
title |
Papilomatose de laringe |
spellingShingle |
Papilomatose de laringe von Mülen, Carla Papilomatose laríngea papiloma vírus humano (HPV) laser CO2 tratamento adjuvante Laryngeal papillomatosis human papilloma virus (HPV) carbon dioxide laser adjuvant treatment |
title_short |
Papilomatose de laringe |
title_full |
Papilomatose de laringe |
title_fullStr |
Papilomatose de laringe |
title_full_unstemmed |
Papilomatose de laringe |
title_sort |
Papilomatose de laringe |
author |
von Mülen, Carla |
author_facet |
von Mülen, Carla Rigol, Cristiane Melchior, Raquel Argenta, Rodrigo M. Smith, Mariana S. Miura, Maurício Kuhl, Gabriel |
author_role |
author |
author2 |
Rigol, Cristiane Melchior, Raquel Argenta, Rodrigo M. Smith, Mariana S. Miura, Maurício Kuhl, Gabriel |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
von Mülen, Carla Rigol, Cristiane Melchior, Raquel Argenta, Rodrigo M. Smith, Mariana S. Miura, Maurício Kuhl, Gabriel |
dc.subject.por.fl_str_mv |
Papilomatose laríngea papiloma vírus humano (HPV) laser CO2 tratamento adjuvante Laryngeal papillomatosis human papilloma virus (HPV) carbon dioxide laser adjuvant treatment |
topic |
Papilomatose laríngea papiloma vírus humano (HPV) laser CO2 tratamento adjuvante Laryngeal papillomatosis human papilloma virus (HPV) carbon dioxide laser adjuvant treatment |
description |
Laryngeal papillomatosis is the most frequent benign neoplasm of the larynx, occurring in children and adults. It is caused by the human papilloma virus, especially types 6 and 11. The clinical course is unpredictable and recurrence is frequent in children. There have been reports of association between this disease and tracheobronchial tree and squamous cell carcinoma of the larynx. Papillomatosis is probably one of thefactors that can predispose a patient to the development of cancer, similarly to alcohol, tobacco, and radiation exposure.Treatment aims at maintaining airway patency and speech. Surgery with carbon dioxide laser is able to achieve this objective, however, without preventing recidivation. The low rates of surgical cure have been stimulating new research with chemotherapics. Unfortunately these have not been successful. Their main purpose is to reduce the extension of the disease and rates of recidivation, slowing down papilloma growth.The present study reviews pathophysiology, the clinical presentation and treatment aspects . |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-06-13 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Peer-reviewed Article" A Convite dos Editores |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/125224 |
url |
https://seer.ufrgs.br/index.php/hcpa/article/view/125224 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://seer.ufrgs.br/index.php/hcpa/article/view/125224/85175 |
dc.rights.driver.fl_str_mv |
http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
publisher.none.fl_str_mv |
HCPA/FAMED/UFRGS |
dc.source.none.fl_str_mv |
Clinical & Biomedical Research; Vol. 19 No. 2 (1999): Revista HCPA Clinical and Biomedical Research; v. 19 n. 2 (1999): Revista HCPA 2357-9730 reponame:Clinical and Biomedical Research instname:Universidade Federal do Rio Grande do Sul (UFRGS) instacron:UFRGS |
instname_str |
Universidade Federal do Rio Grande do Sul (UFRGS) |
instacron_str |
UFRGS |
institution |
UFRGS |
reponame_str |
Clinical and Biomedical Research |
collection |
Clinical and Biomedical Research |
repository.name.fl_str_mv |
Clinical and Biomedical Research - Universidade Federal do Rio Grande do Sul (UFRGS) |
repository.mail.fl_str_mv |
||cbr@hcpa.edu.br |
_version_ |
1799767056889937920 |